In vivo distribution of polymeric nanoparticles at the whole-body, tumor, and cellular levels.
about
Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines.Doxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking.Polymeric micelles in anticancer therapy: targeting, imaging and triggered release.Effect of small-molecule modification on single-cell pharmacokinetics of PARP inhibitorsFRET-enabled biological characterization of polymeric micelles.Intratumoral drug delivery with nanoparticulate carriers.Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities.Development and in vivo quantitative magnetic resonance imaging of polymer micelles targeted to the melanocortin 1 receptor.Polymeric micelles for neoadjuvant cancer therapy and tumor-primed optical imaging.Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles.Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.Block copolymer nanoassemblies for photodynamic therapy and diagnosis.Radiolabeling polymeric micelles for in vivo evaluation: a novel, fast, and facile method.In vitro microfluidic models of tumor microenvironment to screen transport of drugs and nanoparticles.Scientific and industrial challenges of developing nanoparticle-based theranostics and multiple-modality contrast agents for clinical application.Strategies for improving the intratumoral distribution of liposomal drugs in cancer therapy.A novel solid lipid nanoparticle formulation for active targeting to tumor α(v) β(3) integrin receptors reveals cyclic RGD as a double-edged sword.Complex effects of tumor microenvironment on the tumor disposition of carrier-mediated agents.Distribution of PLGA-modified nanoparticles in 3D cell culture models of hypo-vascularized tumor tissue.Quantifying the effects of antiangiogenic and chemotherapy drug combinations on drug delivery and treatment efficacy.Passive tumour targeting and extravasation of cylindrical polymer brushes in mouse xenografts.Particle morphology: an important factor affecting drug delivery by nanocarriers into solid tumors.The Binding Site Barrier Elicited by Tumor-Associated Fibroblasts Interferes Disposition of Nanoparticles in Stroma-Vessel Type Tumors.(89) Zr- and Fe-Labeled Polymeric Micelles for Dual Modality PET and T1 -Weighted MR Imaging.Progress and challenges towards targeted delivery of cancer therapeutics.Distribution of Glutathione-Stabilized Gold Nanoparticles in Feline Fibrosarcomas and Their Role as a Drug Delivery System for Doxorubicin-Preclinical Studies in a Murine Model.Solid tumor-targeting theranostic polymer nanoparticle in nuclear medicinal fields.Application of polymersomes engineered to target p32 protein for detection of small breast tumors in mice.111In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells.
P2860
Q27002209-229323AA-BC1C-4211-98E4-EFF05FA64A98Q30472420-282004C2-FDED-47B2-A455-2F3F7527CFE8Q30478123-A7BB7BBD-028F-4E26-9BD3-BB86610359C0Q30575798-E07A1431-43CD-44A4-8EE5-85A053BC57C4Q33693454-1021AC3B-38C3-487A-996E-820331E21CA8Q35091415-9D11E2AD-857D-451B-A1D1-C5BE00B79C1CQ36803827-54FD417E-769F-4046-BF40-A02B59956427Q37254458-4553DD54-D2AC-47E8-B7AC-61BC4A4FE97BQ37427858-5C70C602-15F3-4AEB-86E5-2CF9D8A6E106Q37476252-77F794D5-F292-42DC-828D-BCAC9EACA029Q38067265-E18A4E92-3103-4C15-987F-48ECB61C5EB6Q38162493-2205335A-F919-4551-9DAA-536BF167E3F7Q38327170-5DACB894-4273-487E-A252-40CF0A191729Q38405765-14A16FBE-852B-40EB-9F58-069D443C4656Q38591130-73B54966-1932-4AE1-8E02-F4E3DF90CB3FQ38776676-69F700BC-B79E-4C9E-A509-71ACC5064C42Q39237707-5B2BAA1D-11E9-4A26-B5D2-D1C647246579Q39458957-2561E19B-8FA6-4A04-A051-A0D7AFDF1D4FQ42114884-F8C7DA3A-EFC7-4636-984B-619F5711064AQ42708321-FDEA2011-F44B-47EC-A576-D42343009CC3Q48748364-8C511162-B517-4256-8B11-5BE11C3239ADQ49628457-DD3030A2-1B8D-44AF-B5BE-72F186D2DE41Q50579985-7FBE5410-1E20-43DB-9DAE-9BC85A8D2AF7Q51786439-6BFFF74E-5DEA-4198-8E35-310505741A35Q52590993-27C8EDA5-549A-437F-98DE-6EE04AEDB266Q52622309-6ACBCC3C-1182-4884-8818-AEB788E2A62AQ53395692-6730DD31-47A9-44BD-BA60-062A79359341Q55267046-85671BA3-3493-487E-B047-BB3559479998Q55334502-4EF4ABB5-ED08-4ACD-B83B-B481FDF8D4E0
P2860
In vivo distribution of polymeric nanoparticles at the whole-body, tumor, and cellular levels.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
In vivo distribution of polyme ...... y, tumor, and cellular levels.
@en
In vivo distribution of polyme ...... y, tumor, and cellular levels.
@nl
type
label
In vivo distribution of polyme ...... y, tumor, and cellular levels.
@en
In vivo distribution of polyme ...... y, tumor, and cellular levels.
@nl
prefLabel
In vivo distribution of polyme ...... y, tumor, and cellular levels.
@en
In vivo distribution of polyme ...... y, tumor, and cellular levels.
@nl
P2093
P2860
P1476
In vivo distribution of polyme ...... y, tumor, and cellular levels.
@en
P2093
Bryan Hoang
Christine Allen
Humphrey Fonge
Raymond M Reilly
P2860
P304
P356
10.1007/S11095-010-0068-Z
P577
2010-03-02T00:00:00Z